XML 74 R133.htm IDEA: XBRL DOCUMENT v3.20.1
Note 12 - Related Party Transactions (Details Textual)
1 Months Ended 3 Months Ended 12 Months Ended 13 Months Ended
Oct. 01, 2017
CAD ($)
Sep. 30, 2022
CAD ($)
Mar. 31, 2020
USD ($)
a
Mar. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Jan. 31, 2018
CAD ($)
Dec. 14, 2017
Dec. 03, 2017
Dec. 02, 2017
Jul. 12, 2017
Area of Land (Acre) | a     10.4                  
Operating Lease, Right-of-Use Asset     $ 199,060   $ 229,284            
Operating Lease, Liability, Total     199,470   228,624              
Lease Arrangement, 20 North Rear Road [Member]                        
Operating Lease, Monthly Rent     8,719 $ 5,986       $ 4,000        
Lessee, Operating Lease, Term of Contract (Year)               5 years        
Operating Lease, Right-of-Use Asset     55,451 68,547                
Operating Lease, Liability, Total     $ 52,632 $ 65,467                
Lessee, Operating Lease, Discount Rate     8.00% 8.00%                
Leases Office Space from R&D Labs Canada, Inc [Member]                        
Operating Lease, Monthly Rent $ 2,608 $ 3,390                    
Operating Lease, Right-of-Use Asset     $ 143,609   160,737              
Operating Lease, Liability, Total     $ 146,838   163,157              
Lessee, Operating Lease, Discount Rate     8.00% 8.00%                
Leases Office Space from R&D Labs Canada, Inc [Member] | General and Administrative Expense [Member]                        
Operating Lease, Expense     $ 6,325 $ 4,978                
Former CEO [Member]                        
Ownership Percentage     5.00%                  
Long-term Convertible Notes Payable to Multiple Private Investors [Member]                        
Debt Instrument, Interest Rate, Stated Percentage                       5.00%
CEN Biotech Ukraine [Member] | XN Pharma [Member]                        
Ownership Percentage     49.00%           49.00%      
CEN Biotech Ukraine [Member]                        
Percentage of Related Party's Equity Interest Owned by Director                 25.50%      
Business Acquisition, Percentage of Voting Interests Acquired                 51.00%      
CEN Biotech Ukraine [Member]                        
Due from Related Parties, Total     $ 1,065,328   1,065,328 875,328            
Percentage of Related Party's Equity Interest Owned by Director                   25.50% 51.00%  
CEN Biotech Ukraine [Member] | Equipment Sold to Related Party in Exchange for Note Receivable [Member]                        
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings             $ 255,141          
Notes Receivable, Related Parties             44,859          
Joseph Byrne [Member]                        
Related Party Transaction, Due from (to) Related Party, Current, Total     (8,347)                  
Board Members and Officers [Member] | Consulting Fees [Member]                        
Related Party Transaction, Amounts of Transaction     31,200 $ 31,200 154,517 150,778            
Due to Related Parties, Total     $ 295,100   $ 263,900 $ 124,800            
R&D Labs Canada, Inc [Member] | Purchased Equipment in Exchange for Note Payable [Member]                        
Notes Payable, Related Parties             $ 300,000